Ireland is participating in a Procurement Exercise being operated by the European Commission on behalf of Member States to procure suitable, safe and effective vaccines, in sufficient quantities, to combat COVID-19.
Six APAs have been negotiated by the Commission under this process to date. Ireland has opted-in to five APAs to secure vaccine supplies: BioNTech/Pfizer, Moderna, AstraZeneca, Janssen/J&J and CureVac.
Under each APA, vaccine doses are allocated pro rata based on participating Member States’ populations and are subsequently purchased by those individual Member States.